Lung Cancer Research Foundation (LCRF): Research Award on Innovative Therapeutic Strategies to Treat ALK Positive Lung Cancers

Name: Lung Cancer Research Foundation (LCRF): Research Award on Innovative Therapeutic Strategies to Treat ALK Positive Lung Cancers
Application deadline: 01/09/23
General description:

Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across the care continuum and has the potential to increase survivorship. Given the specific interest in the development of novel therapies that could benefit this group of patients in the relatively near-term, a clinical trial must be associated with the project. Funding: up to $2M, over 3 years. (Non-profit) 

https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2023/

 

 

Source: Foreign
Budget: up to $2M, over 3 years. (Non-profit) 
Number of research years: 3 years
Contact person: Robi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@campus.technion.ac.il; Orly, 1588, bakarev@trdf.technion.ac.il
Fields: Life Sciences and medicine
Type of fund: The fund is not a competitive fund
Related fund and profiles: Lung Cancer Research Foundation ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)